Literature DB >> 17766517

Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit.

Elizabeth N Lewis1, Marie R Griffin, Peter G Szilagyi, Yuwei Zhu, Kathryn M Edwards, Katherine A Poehling.   

Abstract

OBJECTIVE: The goal was to assess the potential benefits of the influenza vaccine recommendations for children 6 to 59 months of age by estimating the number of children needed to be vaccinated to prevent 1 hospitalization or 1 outpatient visit attributable to influenza.
METHODS: The influenza burden was obtained from published studies in which rates for children 6 to 23 months and 24 to 59 months of age could be ascertained. We assumed a range of influenza vaccine efficacies of 25% to 75%, consistent with the literature. We estimated the number of children who needed to be vaccinated to prevent 1 influenza-attributable hospitalization or 1 outpatient visit for each age group.
RESULTS: As both vaccine efficacy and severity of the influenza season increased, the number of children who needed to be vaccinated to prevent 1 hospitalization or 1 outpatient visit decreased. The numbers of children who needed to be vaccinated to prevent 1 hospitalization in a year with 50% vaccine efficacy ranged from 1031 to 3050 for children 6 to 23 months of age and from 4255 to 6897 for children 24 to 59 months of age. For every 12 to 42 children 6 to 59 months of age vaccinated in a year with 50% vaccine efficacy, we estimated that 1 influenza-attributable outpatient visit would be prevented.
CONCLUSIONS: With 1 outpatient visit being prevented through vaccination of <50 children, influenza vaccination can reduce influenza-attributable medical visits in children significantly, even in years with modest vaccine efficacy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766517     DOI: 10.1542/peds.2007-0167

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review.

Authors:  M R Hoek; H Christensen; W Hellenbrand; P Stefanoff; M Howitz; J M Stuart
Journal:  Epidemiol Infect       Date:  2008-06-18       Impact factor: 2.451

2.  Number Needed to Quarantine and Proportion of Prevented Infectious Days by Quarantine: Evaluating the Effectiveness of COVID-19 Contact Tracing.

Authors:  Diogo Fernandes da Silva; João Vasco Santos; Filipa Santos Martins
Journal:  Public Health Rep       Date:  2022-08-20       Impact factor: 3.117

3.  Critical evaluation of unscientific arguments disparaging affirmative infant male circumcision policy.

Authors:  Brian J Morris; John N Krieger; Jeffrey D Klausner
Journal:  World J Clin Pediatr       Date:  2016-08-08

4.  Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons.

Authors:  Katherine W Eisenberg; Peter G Szilagyi; Gerry Fairbrother; Marie R Griffin; Mary Staat; Laura P Shone; Geoffrey A Weinberg; Caroline B Hall; Katherine A Poehling; Kathryn M Edwards; Geraldine Lofthus; Susan G Fisher; Carolyn B Bridges; Marika K Iwane
Journal:  Pediatrics       Date:  2008-11       Impact factor: 7.124

5.  Number needed to immunize to prevent RSV with extended half-life monoclonal antibody.

Authors:  Lyn Finelli; Yoonyoung Choi; Edward Goldstein
Journal:  Vaccine       Date:  2020-06-26       Impact factor: 3.641

Review 6.  The Relationship between Neonatal Circumcision, Urinary Tract Infection, and Health.

Authors:  Michael L Eisenberg; Deron Galusha; William A Kennedy; Mark R Cullen
Journal:  World J Mens Health       Date:  2018-03-22       Impact factor: 5.400

7.  Critical evaluation of arguments opposing male circumcision: A systematic review.

Authors:  Brian J Morris; Stephen Moreton; John N Krieger
Journal:  J Evid Based Med       Date:  2019-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.